Cellular immunoregulation of Traditonal Chinese Medicine Huangqi in treating patients with chronic hepatitis B by  intravenous injection
	    		
		   		
	    	
    	
    	
   		
        
        	
        		- VernacularTitle:黄芪静脉滴注对慢性乙型病毒性肝炎患者细胞免疫功能的影响
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Jun DONG
			        		
			        		;
		        		
		        		
		        		
			        		Jianyong LIU
			        		
			        		;
		        		
		        		
		        		
			        		Mobin WAN
			        		
			        		;
		        		
		        		
		        		
			        		Xiantuan TANG
			        		
			        		;
		        		
		        		
		        		
			        		Juzhen ZHU
			        		
			        		;
		        		
		        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		hepatitis B;
			        		
			        		
			        		
				        		drug therapy;
			        		
			        		
			        		
				        		astragalus membranaceus;
			        		
			        		
			        		
				        		immunology, cellular
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Academic Journal of Second Military Medical University
	            		
	            		 2000;0(07):-
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective: To study the cellular immunoregulatory effect of Huangqi through intravenous injection in patients with chronic hepatitis B. Methods: In treated groups, light and mild chronic hepatitis B (15 patients in each group) were treated with Huangqi and Ganlixin. In control groups, 10 patients in each group with light and mild chronic hepatitis B were treated with Ganlixin. Normal control group included 10 healthy volunteers. Results: Compared with control group, the level of CD3  +, CD4  + and CD4  + /CD8  + in treatment group increased significantly (  P